BAMF
FLGT icon

BI Asset Management Fondsmaeglerselskab’s Fulgent Genetics FLGT Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-40,106
Closed -$4.03M – 479
2021
Q4 		$4.03M Buy
+40,106
New +$3.52M 0.15% 134
2021
Q2 		– Sell
-31,715
Closed -$3.06M – 416
2021
Q1 		$3.06M Buy
+31,715
New +$3.27M 0.12% 144

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's FLGT Position: Q1 2022 in Review

BI Asset Management Fondsmaeglerselskab sold out of Fulgent Genetics (FLGT) in Q1 2022, closing a stake of 40,106 shares — an estimated $4.03M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in FLGT in Q1 2021 and held it in 2 quarters. The position peaked at $4.03M in Q4 2021. 275 funds tracked by Wall St. Rank hold FLGT as of Q1 2022.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Fulgent Genetics position as of Q1 2022 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 40,106 Fulgent Genetics shares in Q1 2022, an estimated $4.03M.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Fulgent Genetics in Q1 2021 and held it in 2 quarters.
  • BI Asset Management Fondsmaeglerselskab's Fulgent Genetics position peaked at $4.03M in Q4 2021.
  • 275 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2022.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2022, filed 11 May 2022.